Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2089-2025

ADVIA 120/2120/2120i 3-in-1 TESTpoint Control (ABN2 Control) Recall

ADVIA¿ 120/2120/2120i 3-in-1 TESTpoint Control (ABN2 Control)

FDA recall Class II

Ongoing

FDA lists this Class II recall for ADVIA 120/2120/2120i 3-in-1 TESTpoint Control (ABN2 Control). Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2089-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Jun 4, 2025
FDA report date
Jul 9, 2025
Quantity in commerce
3,266 units
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

ADVIA 120/2120/2120i 3-in-1 TESTpoint Control (ABN2 Control)

Affected model & UDI checker

Search the exact identifiers published for Z-2089-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedADVIA 120/2120/2120i 3-in-1 TESTpoint Control (ABN2 Control)Check source notice00630414473413
FDA code information

Siemens Material Number 10318905; UDI: 00630414473413, 00630414473413; Lot No. TP253035, TP253045.

View the original FDA recall notice

Why was this product recalled?

Products have the incorrect platelet (PLT) value assignments for the ADVIA 120/2120/2120i Hematology Systems.

What actions did Siemens Healthcare Diagnostics, Inc. take?

An Urgent Medical Device Correction notification dated 6/4/25 was mailed to consignees. This notification provides consignees with calibration instructions given the issue found in affected lots. Additionally, instructions are given on how to proceed with product depending on performance. Consignees are to discontinue use of and discard of the calibrator SETPOINT lots impacted by this recall. Consignee locations are to review the provided notification with their Medical Directors to determine the appropriate course of action. A copy of the recall notification should be retained in laboratory records and shared with users. Consignees are to complete and return the provided Effectiveness Check Form within 30 days of receipt of the recall notification. Consignees with any questions can contact their Siemens Customer Care Center or local Siemens Healthineers technical support representative.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology